Evidence map›Paper›PMID 38494657›Full record

SynthesisJournal of the International AIDS Society2024

Reasons for disengagement from antiretroviral care in the era of "Treat All" in low- or middle-income countries: a systematic review.

Rachael M Burke, Hannah M Rickman, Clarice Pinto, Peter Ehrenkranz, Augustine Choko, Nathan Ford

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Journal of the International AIDS Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Rachael M BurkeClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-2156-5030
Hannah M RickmanClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Clarice PintoGlobal HIV, Hepatitis and STIs Programme, World Health Organisation, Geneva, Switzerland.
Peter EhrenkranzGlobal Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA.ORCID 0000-0003-2028-4779
Augustine ChokoMalawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Nathan FordGlobal HIV, Hepatitis and STIs Programme, World Health Organisation, Geneva, Switzerland.ORCID 0000-0003-1482-3967
London School of Hygiene & Tropical Medicine · GBGates Foundation · USLiverpool School of Tropical Medicine · GBUniversity of Cape Town · ZAWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionDisengagement from antiretroviral therapy (ART) care is an important reason why people living with HIV do not achieve viral load suppression become unwell.

methodsWe searched two databases and conference abstracts from January 2015 to December 2022 for studies which reported reasons for disengagement from ART care. We included quantitative (mainly surveys) and qualitative (in-depth interviews or focus groups) studies conducted after "treat all" or "Option B+" policy adoption. We used an inductive approach to categorize reasons: we report how often reasons were reported in studies and developed a conceptual framework for reasons.

resultsWe identified 21 studies which reported reasons for disengaging from ART care in the "Treat All" era, mostly in African countries: six studies in the general population of persons living with HIV, nine in pregnant or postpartum women and six in selected populations (one each in people who use drugs, isolated indigenous communities, men, women, adolescents and men who have sex with men). Reasons reported were: side effects or other antiretroviral tablet issues (15 studies); lack of perceived benefit of ART (13 studies); psychological, mental health or drug use (13 studies); concerns about stigma or confidentiality (14 studies); lack of social or family support (12 studies); socio-economic reasons (16 studies); health facility-related reasons (11 studies); and acute proximal events such as unexpected mobility (12 studies). The most common reasons for disengagement were unexpected events, socio-economic reasons, ART side effects or lack of perceived benefit of ART. Conceptually, studies described underlying vulnerability factors (individual, interpersonal, structural and healthcare) but that often unexpected proximal events (e.g. unanticipated mobility) acted as the trigger for disengagement to occur. DISCUSSION: People disengage from ART care for individual, interpersonal, structural and healthcare reasons, and these reasons overlap and interact with each other. While HIV programmes cannot predict and address all events that may lead to disengagement, an approach that recognizes that such shocks will happen could help.

conclusionsHealth services should focus on ways to encourage clients to engage with care by making ART services welcoming, person-centred and more flexible alongside offering adherence interventions, such as counselling and peer support.

Indexed as

Anti-Retroviral AgentsHIV InfectionsMedication AdherencePatient DropoutsAdolescentDeveloping CountriesFemaleHumansMalePregnancySexual and Gender MinoritiesAnti-Retroviral Agentsantiretroviralcare cascadedisengagementloss to carereasonsre-engagement

Identifiers

PMID38494657
PMCPMC10945039
OpenAlexW4392922159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.